Bohnen Shane 4

4 · BIO-TECHNE Corp · Filed Apr 7, 2026

AI-generated summary of this filing

Updated Apr 7, 2026

Bio-Techne SVP Shane Bohnen Receives 2,259 RSUs; 740 Withheld

What Happened

Shane Bohnen, SVP and General Counsel of Bio‑Techne (TECH), had 2,259 restricted stock units vest on April 3, 2026 (reported Apr 7, 2026). Of those shares, 740 were withheld to cover tax withholding at $53.13 per share (total value $39,316). The filing shows the vesting/conversion (transaction code M) and the tax withholding (transaction code F).

Key Details

Transaction dates: vesting/conversion and withholding occurred 2026-04-03; Form 4 filed 2026-04-07 (timely).
Prices and values: withheld 740 shares at $53.13 = $39,316. The RSUs converted/vested at $0 on the form (typical reporting for RSU vesting/conversion); the economic value is implied by the market price used for withholding.
Net new shares received: 2,259 vested − 740 withheld = 1,519 shares retained by Bohnen.
Shares owned after transaction: not specified in the provided filing excerpt.
Relevant footnote: F5 indicates "2,259 restricted stock units vest on 4/3/2026." Transaction codes: M = exercise/conversion of derivative (here, RSU vesting/conversion); F = payment of exercise price or tax liability (withholding).
No indication of a 10b5‑1 plan, gift, or open‑market sale in this filing.

Context

This was a routine vesting of RSUs with shares withheld to satisfy tax obligations (a common cashless withholding). That withholding is not an open‑market sale signaling a deliberate sell decision; it’s to cover taxes. The filing appears timely under Form 4 rules.

Form 4

Period: 2026-04-03

SVP - General Counsel

Transactions

Exercise/Conversion
Common Stock
2026-04-03+2,259→ 6,644 total
Tax Payment
Common Stock
2026-04-03$53.13/sh−740$39,316→ 5,904 total
Exercise/Conversion
Restricted Stock Units
[F4][F5]
2026-04-03−2,259→ 0 total
→ Common Stock (2,259 underlying)

Holdings

Stock Option (Right to Buy)
[F1]
Exercise: $47.60Exp: 2026-08-07→ Common Stock (8,848 underlying)
8,848
Stock Option (Right to Buy)
[F1]
Exercise: $66.97Exp: 2027-08-05→ Common Stock (8,944 underlying)
8,944
Stock Option (Right to Buy)
[F1]
Exercise: $120.46Exp: 2028-08-06→ Common Stock (3,460 underlying)
3,460
Stock Option (Right to Buy)
[F2]
Exercise: $94.52Exp: 2029-08-15→ Common Stock (3,508 underlying)
3,508
Stock Option (Right to Buy)
[F3]
Exercise: $73.76Exp: 2030-04-03→ Common Stock (3,928 underlying)
3,928
Stock Option (Right to Buy)
[F6]
Exercise: $84.61Exp: 2030-08-15→ Common Stock (16,302 underlying)
16,302
Restricted Stock Units
[F4][F7]
→ Common Stock (49 underlying)
49
Performance Restricted Stock Units
[F4][F8]
→ Common Stock (4,802 underlying)
4,802
Performance Stock Option (Right to Buy)
[F8]
Exercise: $84.61→ Common Stock (12,924 underlying)
12,924
Performance Restricted Stock Units
[F4][F9]
→ Common Stock (10,012 underlying)
10,012
Restricted Stock Units
[F4][F10]
→ Common Stock (3,338 underlying)
3,338
Stock Option (Right to Buy)
[F11]
Exercise: $74.91Exp: 2034-08-15→ Common Stock (13,488 underlying)
13,488
Performance Restricted Stock Units
[F4][F12]
→ Common Stock (13,992 underlying)
13,992
Restricted Stock Units
[F4][F13]
→ Common Stock (6,996 underlying)
6,996
Stock Option (Right to Buy)
[F14]
Exercise: $53.60Exp: 2035-08-15→ Common Stock (17,897 underlying)
17,897

Footnotes (14)

[F1]Fully exercisable.
[F10]1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
[F11]Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F12]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F13]2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
[F14]Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
[F2]Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
[F3]Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
[F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F5]2,259 restricted stock units vest on 4/3/2026.
[F6]Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
[F7]49 restricted stock units vest on 8/15/2026.
[F8]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Signature

/s/ Shane Bohnen|2026-04-07

2 files